Abeona’s skin disease cell therapy launch stymied by false-positive sterility test

Abeona Therapeutics said the commercial rollout of its rare skin disease cell therapy has hit a roadbump, delaying the treatment of its first patient by several months. Although the company noted on Wednesday morning that ...